

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, alternative pathway (GO:0006957) | 4.85021096 |
| 2 | negative regulation of lipase activity (GO:0060192) | 4.41179955 |
| 3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.27839714 |
| 4 | primary alcohol catabolic process (GO:0034310) | 4.22906506 |
| 5 | ethanol oxidation (GO:0006069) | 4.17191818 |
| 6 | regulation of protein activation cascade (GO:2000257) | 4.11564377 |
| 7 | regulation of cholesterol esterification (GO:0010872) | 4.08130951 |
| 8 | regulation of complement activation (GO:0030449) | 4.07223288 |
| 9 | protein carboxylation (GO:0018214) | 3.99646828 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.99646828 |
| 11 | low-density lipoprotein particle remodeling (GO:0034374) | 3.86347387 |
| 12 | protein-lipid complex assembly (GO:0065005) | 3.83372283 |
| 13 | high-density lipoprotein particle remodeling (GO:0034375) | 3.80166359 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.79812802 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 3.79812802 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 3.78937728 |
| 17 | tryptophan catabolic process (GO:0006569) | 3.78937728 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 3.78937728 |
| 19 | aromatic amino acid family catabolic process (GO:0009074) | 3.77515242 |
| 20 | ethanol metabolic process (GO:0006067) | 3.75353743 |
| 21 | phospholipid efflux (GO:0033700) | 3.72373450 |
| 22 | negative regulation of cholesterol transport (GO:0032375) | 3.67607387 |
| 23 | negative regulation of sterol transport (GO:0032372) | 3.67607387 |
| 24 | positive regulation of extracellular matrix organization (GO:1903055) | 3.66694958 |
| 25 | reverse cholesterol transport (GO:0043691) | 3.65257601 |
| 26 | tryptophan metabolic process (GO:0006568) | 3.64933820 |
| 27 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.63845220 |
| 28 | cellular glucuronidation (GO:0052695) | 3.59571997 |
| 29 | diterpenoid biosynthetic process (GO:0016102) | 3.55097487 |
| 30 | uronic acid metabolic process (GO:0006063) | 3.53607694 |
| 31 | glucuronate metabolic process (GO:0019585) | 3.53607694 |
| 32 | L-phenylalanine metabolic process (GO:0006558) | 3.53251852 |
| 33 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.53251852 |
| 34 | drug catabolic process (GO:0042737) | 3.51115220 |
| 35 | glyoxylate metabolic process (GO:0046487) | 3.51046909 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.50925602 |
| 37 | epoxygenase P450 pathway (GO:0019373) | 3.50011452 |
| 38 | bile acid biosynthetic process (GO:0006699) | 3.49531071 |
| 39 | retinal metabolic process (GO:0042574) | 3.48859382 |
| 40 | complement activation (GO:0006956) | 3.46895334 |
| 41 | alpha-linolenic acid metabolic process (GO:0036109) | 3.46856920 |
| 42 | homocysteine metabolic process (GO:0050667) | 3.40502982 |
| 43 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.40185065 |
| 44 | regulation of metalloenzyme activity (GO:0048552) | 3.39565095 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 3.35351435 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 3.35351435 |
| 47 | macromolecular complex remodeling (GO:0034367) | 3.35351435 |
| 48 | sulfur amino acid catabolic process (GO:0000098) | 3.33271546 |
| 49 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.32344758 |
| 50 | negative regulation of coagulation (GO:0050819) | 3.30837924 |
| 51 | exogenous drug catabolic process (GO:0042738) | 3.29900234 |
| 52 | daunorubicin metabolic process (GO:0044597) | 3.28666992 |
| 53 | polyketide metabolic process (GO:0030638) | 3.28666992 |
| 54 | doxorubicin metabolic process (GO:0044598) | 3.28666992 |
| 55 | negative regulation of blood coagulation (GO:0030195) | 3.25313180 |
| 56 | negative regulation of hemostasis (GO:1900047) | 3.25313180 |
| 57 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.25240519 |
| 58 | kynurenine metabolic process (GO:0070189) | 3.24675241 |
| 59 | L-ascorbic acid metabolic process (GO:0019852) | 3.23155983 |
| 60 | plasma lipoprotein particle clearance (GO:0034381) | 3.21600005 |
| 61 | * primary alcohol metabolic process (GO:0034308) | 3.20632627 |
| 62 | phospholipid homeostasis (GO:0055091) | 3.20390222 |
| 63 | glutathione derivative metabolic process (GO:1901685) | 3.16380485 |
| 64 | glutathione derivative biosynthetic process (GO:1901687) | 3.16380485 |
| 65 | protein-lipid complex subunit organization (GO:0071825) | 3.14046742 |
| 66 | negative regulation of wound healing (GO:0061045) | 3.13114314 |
| 67 | complement activation, classical pathway (GO:0006958) | 3.13037913 |
| 68 | drug metabolic process (GO:0017144) | 3.11388232 |
| 69 | regulation of cholesterol transport (GO:0032374) | 3.11311953 |
| 70 | regulation of sterol transport (GO:0032371) | 3.11311953 |
| 71 | protein activation cascade (GO:0072376) | 3.09339559 |
| 72 | regulation of plasminogen activation (GO:0010755) | 3.08606337 |
| 73 | cholesterol efflux (GO:0033344) | 3.07859914 |
| 74 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.06068829 |
| 75 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.04898005 |
| 76 | modulation by symbiont of host immune response (GO:0052553) | 3.04898005 |
| 77 | positive regulation by symbiont of host defense response (GO:0052509) | 3.04898005 |
| 78 | modulation by symbiont of host defense response (GO:0052031) | 3.04898005 |
| 79 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.04898005 |
| 80 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.04898005 |
| 81 | cholesterol homeostasis (GO:0042632) | 3.04873029 |
| 82 | regulation of fibrinolysis (GO:0051917) | 3.03652721 |
| 83 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.01373572 |
| 84 | negative regulation of complement activation (GO:0045916) | 2.98857143 |
| 85 | positive regulation of hemostasis (GO:1900048) | 2.98343931 |
| 86 | positive regulation of blood coagulation (GO:0030194) | 2.98343931 |
| 87 | regulation of cholesterol storage (GO:0010885) | 2.97018113 |
| 88 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.97010065 |
| 89 | sterol homeostasis (GO:0055092) | 2.96862799 |
| 90 | fibrinolysis (GO:0042730) | 2.96198238 |
| 91 | regulation of triglyceride catabolic process (GO:0010896) | 2.94570774 |
| 92 | urea metabolic process (GO:0019627) | 2.94465120 |
| 93 | urea cycle (GO:0000050) | 2.94465120 |
| 94 | cobalamin metabolic process (GO:0009235) | 2.93850821 |
| 95 | progesterone metabolic process (GO:0042448) | 2.92963937 |
| 96 | positive regulation of interferon-alpha production (GO:0032727) | 2.91972150 |
| 97 | opsonization (GO:0008228) | 2.91759969 |
| 98 | amino-acid betaine metabolic process (GO:0006577) | 2.90874947 |
| 99 | negative regulation of fibrinolysis (GO:0051918) | 2.89664237 |
| 100 | retinoic acid metabolic process (GO:0042573) | 2.89373899 |
| 101 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.88887840 |
| 102 | positive regulation of coagulation (GO:0050820) | 2.88780780 |
| 103 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.87904292 |
| 104 | cellular biogenic amine catabolic process (GO:0042402) | 2.87579751 |
| 105 | amine catabolic process (GO:0009310) | 2.87579751 |
| 106 | pinocytosis (GO:0006907) | 2.87440372 |
| 107 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.87152614 |
| 108 | sterol transport (GO:0015918) | 2.86499144 |
| 109 | cholesterol transport (GO:0030301) | 2.86499144 |
| 110 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.86390344 |
| 111 | negative regulation of humoral immune response (GO:0002921) | 2.86220028 |
| 112 | * retinoid metabolic process (GO:0001523) | 2.85672076 |
| 113 | positive regulation of cholesterol transport (GO:0032376) | 2.85458139 |
| 114 | positive regulation of sterol transport (GO:0032373) | 2.85458139 |
| 115 | positive regulation of cholesterol efflux (GO:0010875) | 2.85419043 |
| 116 | cysteine metabolic process (GO:0006534) | 2.84746841 |
| 117 | bile acid metabolic process (GO:0008206) | 2.81417086 |
| 118 | * retinol metabolic process (GO:0042572) | 2.80982849 |
| 119 | acute-phase response (GO:0006953) | 2.79871627 |
| 120 | detection of molecule of bacterial origin (GO:0032490) | 2.79613880 |
| 121 | blood coagulation, intrinsic pathway (GO:0007597) | 2.77407737 |
| 122 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.77126729 |
| 123 | cellular response to zinc ion (GO:0071294) | 2.76656867 |
| 124 | phenylpropanoid metabolic process (GO:0009698) | 2.76034886 |
| 125 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.75808088 |
| 126 | negative regulation of protein activation cascade (GO:2000258) | 2.75600957 |
| 127 | acylglycerol catabolic process (GO:0046464) | 2.74511675 |
| 128 | neutral lipid catabolic process (GO:0046461) | 2.74511675 |
| 129 | regulation of interferon-alpha production (GO:0032647) | 2.73918610 |
| 130 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.73180963 |
| 131 | plasma lipoprotein particle organization (GO:0071827) | 2.72474735 |
| 132 | cellular response to cadmium ion (GO:0071276) | 2.71730727 |
| 133 | microglial cell activation (GO:0001774) | 2.71718855 |
| 134 | * diterpenoid metabolic process (GO:0016101) | 2.71261893 |
| 135 | valine metabolic process (GO:0006573) | 2.70635820 |
| 136 | transcytosis (GO:0045056) | 2.70316258 |
| 137 | axonemal dynein complex assembly (GO:0070286) | 2.69699844 |
| 138 | aldehyde catabolic process (GO:0046185) | 2.69495214 |
| 139 | acylglycerol homeostasis (GO:0055090) | 2.66299545 |
| 140 | triglyceride homeostasis (GO:0070328) | 2.66299545 |
| 141 | plasma lipoprotein particle assembly (GO:0034377) | 2.63944624 |
| 142 | amyloid precursor protein catabolic process (GO:0042987) | 2.63877151 |
| 143 | lipoprotein metabolic process (GO:0042157) | 2.63181339 |
| 144 | xenobiotic catabolic process (GO:0042178) | 2.62999547 |
| 145 | nitrogen cycle metabolic process (GO:0071941) | 2.62331878 |
| 146 | regulation of cholesterol metabolic process (GO:0090181) | 2.62180246 |
| 147 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.61832703 |
| 148 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.61832703 |
| 149 | neutrophil activation involved in immune response (GO:0002283) | 2.61069145 |
| 150 | fatty acid beta-oxidation (GO:0006635) | 2.59439485 |
| 151 | positive regulation of fatty acid oxidation (GO:0046321) | 2.58989858 |
| 152 | NAD biosynthetic process (GO:0009435) | 2.58826257 |
| 153 | keratan sulfate catabolic process (GO:0042340) | 2.58685986 |
| 154 | indolalkylamine metabolic process (GO:0006586) | 2.58679567 |
| 155 | aromatic amino acid family metabolic process (GO:0009072) | 2.56577649 |
| 156 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.55525512 |
| 157 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.55525512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.38930568 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.51991425 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.81532091 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.05497478 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.02942649 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.96112815 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.83594429 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.40043547 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.29481581 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.89851863 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.76144330 |
| 12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.75424189 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.69342059 |
| 14 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.61818604 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.59529872 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.49803791 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46425960 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.43383382 |
| 19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.35981114 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.25460529 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.15325602 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.10479521 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08359912 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.04079106 |
| 25 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95426847 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.92549991 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.90836856 |
| 28 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.90491706 |
| 29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.82896439 |
| 30 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.77236952 |
| 31 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.76994932 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73452303 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.67564573 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66145387 |
| 35 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.58564229 |
| 36 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53320715 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.52097899 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.49488582 |
| 39 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.46721655 |
| 40 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.46721655 |
| 41 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.46250039 |
| 42 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42195354 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41485773 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40755558 |
| 45 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.39151889 |
| 46 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.39068262 |
| 47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38624597 |
| 48 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.38121890 |
| 49 | CJUN_26792858_Chip-Seq_BT549_Human | 1.37071687 |
| 50 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.33066781 |
| 51 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30995183 |
| 52 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30913007 |
| 53 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29494000 |
| 54 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.27812339 |
| 55 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24687194 |
| 56 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.24245714 |
| 57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23708406 |
| 58 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.19094635 |
| 59 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.18909004 |
| 60 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17729441 |
| 61 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15726527 |
| 62 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.14243356 |
| 63 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13724328 |
| 64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12065674 |
| 65 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.11896171 |
| 66 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11835967 |
| 67 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11802829 |
| 68 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11260009 |
| 69 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.11235929 |
| 70 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.10021736 |
| 71 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.09844722 |
| 72 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.09770214 |
| 73 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.09525301 |
| 74 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09471695 |
| 75 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.07999636 |
| 76 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.06979368 |
| 77 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.05473760 |
| 78 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.04684545 |
| 79 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02194411 |
| 80 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01640855 |
| 81 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01619807 |
| 82 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99558456 |
| 83 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.98166053 |
| 84 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96393300 |
| 85 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.95936142 |
| 86 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94208480 |
| 87 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93634116 |
| 88 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93250779 |
| 89 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92446225 |
| 90 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91969612 |
| 91 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.90135807 |
| 92 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.89563721 |
| 93 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89557978 |
| 94 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89229064 |
| 95 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88793441 |
| 96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88337369 |
| 97 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.88218181 |
| 98 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.87711973 |
| 99 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.87652516 |
| 100 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.87241932 |
| 101 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.87198618 |
| 102 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86768804 |
| 103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85691781 |
| 104 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.84416783 |
| 105 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84030874 |
| 106 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84030874 |
| 107 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.82922072 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81723850 |
| 109 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.81661311 |
| 110 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81014757 |
| 111 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81014206 |
| 112 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.80999270 |
| 113 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80943610 |
| 114 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80746997 |
| 115 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.80700330 |
| 116 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.80591792 |
| 117 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80109892 |
| 118 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80052799 |
| 119 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79763039 |
| 120 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79738796 |
| 121 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.79507999 |
| 122 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78500749 |
| 123 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.78343563 |
| 124 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.78049154 |
| 125 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76287088 |
| 126 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.74878747 |
| 127 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.74878747 |
| 128 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.74753465 |
| 129 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.74347238 |
| 130 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.73792128 |
| 131 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.73173293 |
| 132 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.71825889 |
| 133 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71471218 |
| 134 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.69771270 |
| 135 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.69418324 |
| 136 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.69263599 |
| 137 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69118025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.48926310 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 4.36181505 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.92004199 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 3.39793820 |
| 5 | MP0005365_abnormal_bile_salt | 3.06687204 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.03153134 |
| 7 | MP0009840_abnormal_foam_cell | 2.89207136 |
| 8 | MP0005275_abnormal_skin_tensile | 2.77569235 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.61912909 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.59345848 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.54732515 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.39346781 |
| 13 | MP0003724_increased_susceptibility_to | 2.35638962 |
| 14 | MP0010368_abnormal_lymphatic_system | 2.35009576 |
| 15 | MP0003252_abnormal_bile_duct | 2.32839950 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.21792210 |
| 17 | MP0005503_abnormal_tendon_morphology | 2.21645414 |
| 18 | MP0004272_abnormal_basement_membrane | 2.18113595 |
| 19 | MP0003436_decreased_susceptibility_to | 2.06545276 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 1.90710663 |
| 21 | MP0003690_abnormal_glial_cell | 1.86386837 |
| 22 | MP0003195_calcinosis | 1.77536889 |
| 23 | MP0005332_abnormal_amino_acid | 1.76902175 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.75794709 |
| 25 | MP0002419_abnormal_innate_immunity | 1.75631336 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.70356532 |
| 27 | MP0004883_abnormal_blood_vessel | 1.70246222 |
| 28 | MP0009764_decreased_sensitivity_to | 1.70234631 |
| 29 | MP0004782_abnormal_surfactant_physiolog | 1.63551517 |
| 30 | MP0003075_altered_response_to | 1.62715507 |
| 31 | MP0003279_aneurysm | 1.56713435 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 1.56355174 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.55971955 |
| 34 | MP0009785_altered_susceptibility_to | 1.50329627 |
| 35 | MP0002254_reproductive_system_inflammat | 1.48067558 |
| 36 | MP0003011_delayed_dark_adaptation | 1.46533617 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.45659710 |
| 38 | MP0000343_altered_response_to | 1.44218656 |
| 39 | MP0001853_heart_inflammation | 1.43501831 |
| 40 | MP0005083_abnormal_biliary_tract | 1.42787155 |
| 41 | MP0005670_abnormal_white_adipose | 1.41012767 |
| 42 | MP0000609_abnormal_liver_physiology | 1.37136642 |
| 43 | MP0001542_abnormal_bone_strength | 1.36524384 |
| 44 | MP0001958_emphysema | 1.34460198 |
| 45 | MP0003186_abnormal_redox_activity | 1.31662211 |
| 46 | MP0002060_abnormal_skin_morphology | 1.31498768 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.30722600 |
| 48 | MP0003806_abnormal_nucleotide_metabolis | 1.28285716 |
| 49 | MP0005164_abnormal_response_to | 1.27360223 |
| 50 | MP0002118_abnormal_lipid_homeostasis | 1.27223275 |
| 51 | MP0003868_abnormal_feces_composition | 1.27075781 |
| 52 | MP0005319_abnormal_enzyme/_coenzyme | 1.26765668 |
| 53 | MP0005025_abnormal_response_to | 1.25125032 |
| 54 | MP0001764_abnormal_homeostasis | 1.24609132 |
| 55 | MP0008469_abnormal_protein_level | 1.23938878 |
| 56 | MP0000681_abnormal_thyroid_gland | 1.23030188 |
| 57 | MP0005023_abnormal_wound_healing | 1.21212455 |
| 58 | MP0001661_extended_life_span | 1.20773145 |
| 59 | MP0006082_CNS_inflammation | 1.20749233 |
| 60 | MP0005387_immune_system_phenotype | 1.19882026 |
| 61 | MP0001790_abnormal_immune_system | 1.19882026 |
| 62 | MP0003828_pulmonary_edema | 1.16859475 |
| 63 | MP0005166_decreased_susceptibility_to | 1.11746619 |
| 64 | MP0000604_amyloidosis | 1.10393963 |
| 65 | MP0005000_abnormal_immune_tolerance | 1.10148294 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.07427296 |
| 67 | MP0010386_abnormal_urinary_bladder | 1.05883587 |
| 68 | MP0009763_increased_sensitivity_to | 1.05751343 |
| 69 | MP0001666_abnormal_nutrient_absorption | 1.04592531 |
| 70 | MP0001845_abnormal_inflammatory_respons | 1.02771812 |
| 71 | MP0000538_abnormal_urinary_bladder | 1.01507564 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.01199308 |
| 73 | MP0003566_abnormal_cell_adhesion | 1.01124615 |
| 74 | MP0002108_abnormal_muscle_morphology | 1.00395023 |
| 75 | MP0000685_abnormal_immune_system | 1.00101305 |
| 76 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99387748 |
| 77 | MP0000249_abnormal_blood_vessel | 0.99335809 |
| 78 | MP0002132_abnormal_respiratory_system | 0.98739295 |
| 79 | MP0002452_abnormal_antigen_presenting | 0.98257320 |
| 80 | MP0005508_abnormal_skeleton_morphology | 0.96737307 |
| 81 | MP0001879_abnormal_lymphatic_vessel | 0.96363989 |
| 82 | MP0002998_abnormal_bone_remodeling | 0.94592451 |
| 83 | MP0005390_skeleton_phenotype | 0.94307426 |
| 84 | MP0002405_respiratory_system_inflammati | 0.93107262 |
| 85 | MP0003448_altered_tumor_morphology | 0.90175591 |
| 86 | MP0002295_abnormal_pulmonary_circulatio | 0.88867460 |
| 87 | MP0001800_abnormal_humoral_immune | 0.88278059 |
| 88 | MP0008775_abnormal_heart_ventricle | 0.88062661 |
| 89 | MP0003300_gastrointestinal_ulcer | 0.86543259 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 0.86401357 |
| 91 | MP0005636_abnormal_mineral_homeostasis | 0.86292645 |
| 92 | MP0010155_abnormal_intestine_physiology | 0.85663715 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.85019107 |
| 94 | MP0002166_altered_tumor_susceptibility | 0.84726049 |
| 95 | MP0001243_abnormal_dermal_layer | 0.84718118 |
| 96 | MP0006138_congestive_heart_failure | 0.84630225 |
| 97 | MP0005595_abnormal_vascular_smooth | 0.83955424 |
| 98 | MP0005257_abnormal_intraocular_pressure | 0.82958819 |
| 99 | MP0000767_abnormal_smooth_muscle | 0.82050300 |
| 100 | MP0003879_abnormal_hair_cell | 0.81054235 |
| 101 | MP0000858_altered_metastatic_potential | 0.81018592 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.79408259 |
| 103 | MP0002723_abnormal_immune_serum | 0.79110635 |
| 104 | MP0002282_abnormal_trachea_morphology | 0.78589515 |
| 105 | MP0000598_abnormal_liver_morphology | 0.78278813 |
| 106 | MP0002971_abnormal_brown_adipose | 0.76038209 |
| 107 | MP0008004_abnormal_stomach_pH | 0.75721266 |
| 108 | MP0002876_abnormal_thyroid_physiology | 0.75687555 |
| 109 | MP0006054_spinal_hemorrhage | 0.75370829 |
| 110 | MP0009115_abnormal_fat_cell | 0.75189452 |
| 111 | MP0002168_other_aberrant_phenotype | 0.74609317 |
| 112 | MP0000465_gastrointestinal_hemorrhage | 0.74472552 |
| 113 | MP0009697_abnormal_copulation | 0.74183309 |
| 114 | MP0004130_abnormal_muscle_cell | 0.72364021 |
| 115 | MP0008872_abnormal_physiological_respon | 0.72352129 |
| 116 | MP0005377_hearing/vestibular/ear_phenot | 0.71567243 |
| 117 | MP0003878_abnormal_ear_physiology | 0.71567243 |
| 118 | MP0003172_abnormal_lysosome_physiology | 0.71259252 |
| 119 | MP0005376_homeostasis/metabolism_phenot | 0.70129622 |
| 120 | MP0001756_abnormal_urination | 0.69523816 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 0.69380236 |
| 122 | MP0001881_abnormal_mammary_gland | 0.69316140 |
| 123 | MP0004947_skin_inflammation | 0.68128922 |
| 124 | MP0008260_abnormal_autophagy | 0.67842901 |
| 125 | MP0005334_abnormal_fat_pad | 0.67670257 |
| 126 | MP0005165_increased_susceptibility_to | 0.67580973 |
| 127 | MP0000467_abnormal_esophagus_morphology | 0.66845746 |
| 128 | MP0004084_abnormal_cardiac_muscle | 0.65575214 |
| 129 | MP0002135_abnormal_kidney_morphology | 0.63708727 |
| 130 | MP0010352_gastrointestinal_tract_polyps | 0.63670921 |
| 131 | MP0001851_eye_inflammation | 0.61743996 |
| 132 | MP0004036_abnormal_muscle_relaxation | 0.61599942 |
| 133 | MP0000613_abnormal_salivary_gland | 0.61538727 |
| 134 | MP0003638_abnormal_response/metabolism_ | 0.59171223 |
| 135 | MP0002933_joint_inflammation | 0.59068321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.31782426 |
| 2 | Complement deficiency (HP:0004431) | 6.30528629 |
| 3 | Glomerulonephritis (HP:0000099) | 5.48594728 |
| 4 | Abnormality of complement system (HP:0005339) | 5.44617875 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 4.48124619 |
| 6 | Joint hemorrhage (HP:0005261) | 4.10119249 |
| 7 | Xanthomatosis (HP:0000991) | 3.94599427 |
| 8 | Deep venous thrombosis (HP:0002625) | 3.87936344 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.61973568 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.60582292 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 3.58063790 |
| 12 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.56912021 |
| 13 | Nephritis (HP:0000123) | 3.52469550 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 3.52310087 |
| 15 | Rhinitis (HP:0012384) | 3.51766633 |
| 16 | Myocardial infarction (HP:0001658) | 3.51182242 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 3.47578895 |
| 18 | Recurrent abscess formation (HP:0002722) | 3.47018120 |
| 19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.37180515 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.35116798 |
| 21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.23577001 |
| 22 | Spontaneous abortion (HP:0005268) | 3.23497103 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 3.16743188 |
| 24 | Protrusio acetabuli (HP:0003179) | 3.16726217 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.15660526 |
| 26 | Petechiae (HP:0000967) | 3.13983005 |
| 27 | Hydroxyprolinuria (HP:0003080) | 3.12787812 |
| 28 | Abnormality of proline metabolism (HP:0010907) | 3.12787812 |
| 29 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.09362656 |
| 30 | Cervical subluxation (HP:0003308) | 3.04588551 |
| 31 | Axonal loss (HP:0003447) | 2.99130379 |
| 32 | Vascular tortuosity (HP:0004948) | 2.97832906 |
| 33 | Hypercholesterolemia (HP:0003124) | 2.95800638 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 2.91760650 |
| 35 | Menorrhagia (HP:0000132) | 2.88492607 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.84649146 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.80025555 |
| 38 | Hyperglycinuria (HP:0003108) | 2.76844528 |
| 39 | Generalized aminoaciduria (HP:0002909) | 2.75202900 |
| 40 | Arterial tortuosity (HP:0005116) | 2.67385295 |
| 41 | Chronic bronchitis (HP:0004469) | 2.64775770 |
| 42 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.62659201 |
| 43 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.58014046 |
| 44 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.58014046 |
| 45 | Male infertility (HP:0003251) | 2.57712693 |
| 46 | Dysostosis multiplex (HP:0000943) | 2.56427362 |
| 47 | Aortic dissection (HP:0002647) | 2.56240034 |
| 48 | Fat malabsorption (HP:0002630) | 2.56118425 |
| 49 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.55677930 |
| 50 | Mitral stenosis (HP:0001718) | 2.54129689 |
| 51 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.47800416 |
| 52 | Osteolytic defects of the hand bones (HP:0009699) | 2.47800416 |
| 53 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.46146334 |
| 54 | Mucopolysacchariduria (HP:0008155) | 2.46146334 |
| 55 | Spontaneous hematomas (HP:0007420) | 2.46121721 |
| 56 | Epidermoid cyst (HP:0200040) | 2.46055045 |
| 57 | Aortic aneurysm (HP:0004942) | 2.46044077 |
| 58 | Spondylolisthesis (HP:0003302) | 2.44049126 |
| 59 | Hyperammonemia (HP:0001987) | 2.43415654 |
| 60 | Hypolipoproteinemia (HP:0010981) | 2.43369797 |
| 61 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.42633546 |
| 62 | Abnormality of carpal bone ossification (HP:0006257) | 2.40964059 |
| 63 | Steatorrhea (HP:0002570) | 2.34473476 |
| 64 | Hypobetalipoproteinemia (HP:0003563) | 2.34044463 |
| 65 | Absent/shortened dynein arms (HP:0200106) | 2.32968800 |
| 66 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.32968800 |
| 67 | Atelectasis (HP:0100750) | 2.32817608 |
| 68 | Abnormality of the intrinsic pathway (HP:0010989) | 2.32122387 |
| 69 | Abnormality of macrophages (HP:0004311) | 2.32100368 |
| 70 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.27839424 |
| 71 | Abnormality of glycine metabolism (HP:0010895) | 2.27839424 |
| 72 | Abnormal ciliary motility (HP:0012262) | 2.26598038 |
| 73 | Periodontitis (HP:0000704) | 2.26564497 |
| 74 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.26206066 |
| 75 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.26206066 |
| 76 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.26206066 |
| 77 | Gingival bleeding (HP:0000225) | 2.25535501 |
| 78 | Pustule (HP:0200039) | 2.25303551 |
| 79 | Cholecystitis (HP:0001082) | 2.24101114 |
| 80 | Abnormal gallbladder physiology (HP:0012438) | 2.24101114 |
| 81 | Cardiovascular calcification (HP:0011915) | 2.23110303 |
| 82 | Esophageal varix (HP:0002040) | 2.21879113 |
| 83 | Pigmentary retinal degeneration (HP:0001146) | 2.20081613 |
| 84 | Malnutrition (HP:0004395) | 2.17711581 |
| 85 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.17502124 |
| 86 | Bronchiectasis (HP:0002110) | 2.15861822 |
| 87 | Progressive visual loss (HP:0000529) | 2.14251727 |
| 88 | Hepatocellular carcinoma (HP:0001402) | 2.14090432 |
| 89 | Abnormality of methionine metabolism (HP:0010901) | 2.12828065 |
| 90 | Abnormality of purine metabolism (HP:0004352) | 2.12710382 |
| 91 | Vascular calcification (HP:0004934) | 2.12602525 |
| 92 | Hypoglycemic coma (HP:0001325) | 2.11751795 |
| 93 | Follicular hyperkeratosis (HP:0007502) | 2.09523617 |
| 94 | Thick nail (HP:0001805) | 2.08756100 |
| 95 | Prolonged bleeding time (HP:0003010) | 2.07836667 |
| 96 | Epistaxis (HP:0000421) | 2.04722766 |
| 97 | Alopecia of scalp (HP:0002293) | 2.04574099 |
| 98 | Ileus (HP:0002595) | 2.04537712 |
| 99 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.04495242 |
| 100 | Abnormality of nucleobase metabolism (HP:0010932) | 2.04364875 |
| 101 | Hyperglycinemia (HP:0002154) | 2.02667235 |
| 102 | Gingivitis (HP:0000230) | 2.01454859 |
| 103 | Conjugated hyperbilirubinemia (HP:0002908) | 1.99754323 |
| 104 | Subcapsular cataract (HP:0000523) | 1.99693977 |
| 105 | Myositis (HP:0100614) | 1.98528624 |
| 106 | Hyperactive renin-angiotensin system (HP:0000841) | 1.98038167 |
| 107 | Hepatosplenomegaly (HP:0001433) | 1.97076813 |
| 108 | Abnormal delivery (HP:0001787) | 1.93548940 |
| 109 | Pancreatitis (HP:0001733) | 1.92863944 |
| 110 | Ketosis (HP:0001946) | 1.92408223 |
| 111 | Nausea (HP:0002018) | 1.91870069 |
| 112 | Orchitis (HP:0100796) | 1.90846784 |
| 113 | Neoplasm of head and neck (HP:0012288) | 1.90668373 |
| 114 | Esophageal neoplasm (HP:0100751) | 1.90668373 |
| 115 | Hematochezia (HP:0002573) | 1.89278991 |
| 116 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.87673861 |
| 117 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87161410 |
| 118 | Increased mean platelet volume (HP:0011877) | 1.86311910 |
| 119 | Recurrent skin infections (HP:0001581) | 1.85556280 |
| 120 | Pathologic fracture (HP:0002756) | 1.85521368 |
| 121 | Amyloidosis (HP:0011034) | 1.85404600 |
| 122 | Interstitial pulmonary disease (HP:0006530) | 1.84438580 |
| 123 | Cerebral palsy (HP:0100021) | 1.84002909 |
| 124 | Hemorrhage of the eye (HP:0011885) | 1.83071132 |
| 125 | Premature rupture of membranes (HP:0001788) | 1.83021295 |
| 126 | Abnormality of the nasal mucosa (HP:0000433) | 1.82672413 |
| 127 | Increased serum ferritin (HP:0003281) | 1.82340975 |
| 128 | Bone cyst (HP:0012062) | 1.82276866 |
| 129 | Dicarboxylic aciduria (HP:0003215) | 1.81643584 |
| 130 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.81643584 |
| 131 | Upper motor neuron abnormality (HP:0002127) | 1.80586837 |
| 132 | Joint swelling (HP:0001386) | 1.80569313 |
| 133 | Hypertriglyceridemia (HP:0002155) | 1.80343536 |
| 134 | Purpura (HP:0000979) | 1.79362761 |
| 135 | Delayed CNS myelination (HP:0002188) | 1.78994133 |
| 136 | Thrombophlebitis (HP:0004418) | 1.78969663 |
| 137 | Alveolar cell carcinoma (HP:0006519) | 1.78761799 |
| 138 | Vertebral compression fractures (HP:0002953) | 1.77962721 |
| 139 | Nasal polyposis (HP:0100582) | 1.76182105 |
| 140 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.74518868 |
| 141 | Occipital encephalocele (HP:0002085) | 1.73468849 |
| 142 | Atrophic scars (HP:0001075) | 1.73345660 |
| 143 | Stridor (HP:0010307) | 1.72472851 |
| 144 | Gout (HP:0001997) | 1.71930354 |
| 145 | Glucose intolerance (HP:0000833) | 1.71718822 |
| 146 | Soft skin (HP:0000977) | 1.70703823 |
| 147 | Exocrine pancreatic insufficiency (HP:0001738) | 1.68499329 |
| 148 | Abnormal glucose tolerance (HP:0001952) | 1.68372944 |
| 149 | Skin nodule (HP:0200036) | 1.68323164 |
| 150 | Abnormal platelet function (HP:0011869) | 1.67455605 |
| 151 | Impaired platelet aggregation (HP:0003540) | 1.67455605 |
| 152 | Abnormal hand bone ossification (HP:0010660) | 1.66873237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 3.75057593 |
| 2 | TGFBR2 | 3.41199011 |
| 3 | MAP3K14 | 3.41054212 |
| 4 | EPHA2 | 3.12191942 |
| 5 | ERN1 | 3.09068947 |
| 6 | BCKDK | 2.77172576 |
| 7 | TYK2 | 2.64105657 |
| 8 | NEK9 | 2.62578224 |
| 9 | IRAK4 | 2.37172731 |
| 10 | MAP3K12 | 2.29229890 |
| 11 | SIK3 | 2.27266444 |
| 12 | DDR2 | 2.20008683 |
| 13 | KIT | 2.16417087 |
| 14 | IRAK3 | 2.14628101 |
| 15 | MET | 2.11703546 |
| 16 | BMPR2 | 1.97112567 |
| 17 | TBK1 | 1.96734492 |
| 18 | FGFR4 | 1.91846255 |
| 19 | PIM2 | 1.84760388 |
| 20 | GRK7 | 1.80294965 |
| 21 | MAP4K2 | 1.80121926 |
| 22 | IKBKE | 1.76917789 |
| 23 | BLK | 1.75039862 |
| 24 | JAK1 | 1.72457837 |
| 25 | NLK | 1.71767578 |
| 26 | MAPKAPK3 | 1.65651556 |
| 27 | EPHB1 | 1.65083600 |
| 28 | IKBKB | 1.63841541 |
| 29 | TIE1 | 1.58940129 |
| 30 | BCR | 1.53288090 |
| 31 | MAP3K3 | 1.48953412 |
| 32 | TRIM28 | 1.46189501 |
| 33 | TEC | 1.43052251 |
| 34 | TRPM7 | 1.42552079 |
| 35 | TAOK3 | 1.41691691 |
| 36 | FRK | 1.40597126 |
| 37 | EPHA3 | 1.40192841 |
| 38 | PTK2 | 1.39503857 |
| 39 | SIK1 | 1.33990804 |
| 40 | BTK | 1.32687286 |
| 41 | TXK | 1.31969026 |
| 42 | TESK1 | 1.30623073 |
| 43 | CDK8 | 1.30510071 |
| 44 | STK24 | 1.28242429 |
| 45 | STK38L | 1.28229413 |
| 46 | AKT3 | 1.27701368 |
| 47 | MST1R | 1.27594176 |
| 48 | CHUK | 1.25633710 |
| 49 | TGFBR1 | 1.23679043 |
| 50 | FLT3 | 1.17289818 |
| 51 | ZAP70 | 1.16709363 |
| 52 | ERBB3 | 1.15774663 |
| 53 | MAP2K3 | 1.15048784 |
| 54 | EIF2AK2 | 1.14015772 |
| 55 | BMPR1B | 1.13884100 |
| 56 | PIK3CG | 1.13794620 |
| 57 | EPHB2 | 1.13320698 |
| 58 | MYLK | 1.11491046 |
| 59 | MAP4K1 | 1.07169961 |
| 60 | TAOK2 | 1.06885937 |
| 61 | JAK2 | 1.04507540 |
| 62 | ADRBK2 | 0.99448160 |
| 63 | MAP3K2 | 0.99092835 |
| 64 | CDK6 | 0.98538118 |
| 65 | ILK | 0.97300739 |
| 66 | RIPK1 | 0.97077406 |
| 67 | CSF1R | 0.96739264 |
| 68 | MUSK | 0.95251806 |
| 69 | PINK1 | 0.94457994 |
| 70 | INSRR | 0.94333148 |
| 71 | CAMK1D | 0.93050406 |
| 72 | FGFR3 | 0.92147139 |
| 73 | NUAK1 | 0.90517869 |
| 74 | PIK3CA | 0.90001859 |
| 75 | STK39 | 0.89274948 |
| 76 | HCK | 0.89060039 |
| 77 | ZAK | 0.86792636 |
| 78 | ACVR1B | 0.86350991 |
| 79 | SGK2 | 0.85300752 |
| 80 | TNIK | 0.83446745 |
| 81 | SGK3 | 0.83327575 |
| 82 | PDK2 | 0.82702224 |
| 83 | STK16 | 0.81880138 |
| 84 | BMX | 0.77864430 |
| 85 | LYN | 0.76680280 |
| 86 | ABL2 | 0.75798106 |
| 87 | YES1 | 0.74110146 |
| 88 | STK10 | 0.73669578 |
| 89 | NME1 | 0.72332170 |
| 90 | MAPK7 | 0.72300448 |
| 91 | GRK5 | 0.71744389 |
| 92 | LATS1 | 0.70584946 |
| 93 | PTK2B | 0.70397710 |
| 94 | PIM1 | 0.69718572 |
| 95 | PTK6 | 0.68372137 |
| 96 | TRIB3 | 0.68296255 |
| 97 | MAPK11 | 0.68205262 |
| 98 | PRKG2 | 0.67524108 |
| 99 | PAK3 | 0.65815882 |
| 100 | CDK9 | 0.64111439 |
| 101 | CSK | 0.64005839 |
| 102 | ROCK1 | 0.62679220 |
| 103 | ITK | 0.62202615 |
| 104 | STK3 | 0.61814423 |
| 105 | GRK1 | 0.61531072 |
| 106 | IGF1R | 0.61421282 |
| 107 | EIF2AK1 | 0.61090227 |
| 108 | ADRBK1 | 0.61008280 |
| 109 | MAP3K7 | 0.60670334 |
| 110 | KDR | 0.59487311 |
| 111 | PDGFRB | 0.59349510 |
| 112 | SYK | 0.59323771 |
| 113 | EIF2AK3 | 0.59231637 |
| 114 | LMTK2 | 0.58857474 |
| 115 | GRK6 | 0.58318703 |
| 116 | NEK6 | 0.58139783 |
| 117 | PAK2 | 0.56601088 |
| 118 | IRAK1 | 0.55930694 |
| 119 | ABL1 | 0.55710659 |
| 120 | MAP2K2 | 0.55144749 |
| 121 | MAP2K1 | 0.54121113 |
| 122 | PKN2 | 0.53730705 |
| 123 | PRKCD | 0.52189840 |
| 124 | PDGFRA | 0.50644483 |
| 125 | MAPK15 | 0.48517068 |
| 126 | JAK3 | 0.48206056 |
| 127 | MAPK12 | 0.47720613 |
| 128 | PBK | 0.47342065 |
| 129 | ERBB2 | 0.47035335 |
| 130 | TTN | 0.46507601 |
| 131 | PRKCE | 0.46467114 |
| 132 | TNK2 | 0.46153747 |
| 133 | RPS6KA6 | 0.44387686 |
| 134 | PAK4 | 0.43843631 |
| 135 | PRKAA2 | 0.43629754 |
| 136 | STK38 | 0.43384228 |
| 137 | FER | 0.42869098 |
| 138 | GSK3A | 0.41911157 |
| 139 | PRKD1 | 0.41847692 |
| 140 | CLK1 | 0.40690182 |
| 141 | MAPK4 | 0.40484057 |
| 142 | RPS6KC1 | 0.40325242 |
| 143 | RPS6KL1 | 0.40325242 |
| 144 | DAPK3 | 0.39764640 |
| 145 | MAPKAPK2 | 0.39567816 |
| 146 | RET | 0.38604643 |
| 147 | LIMK1 | 0.37896746 |
| 148 | MAP3K6 | 0.37760247 |
| 149 | PRKACG | 0.35812364 |
| 150 | CDC42BPA | 0.33587793 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.15938626 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.46272990 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.39423588 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.03728225 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.83529771 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.27966773 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.17457220 |
| 8 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16250676 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.15306804 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.01358363 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.98205401 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.96945808 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95856381 |
| 14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92459355 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.91827449 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 1.88645251 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.72113795 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.70623436 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.69734140 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.66788130 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.62320882 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.62116543 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.60104184 |
| 24 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.59386801 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.55993357 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.55091331 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.51476066 |
| 28 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.48466920 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.46388091 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.39607467 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.37411755 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.27646384 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.27492379 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.27418626 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.26432892 |
| 36 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.23039153 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.22541284 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.18911021 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.18827022 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.17236748 |
| 41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.15949367 |
| 42 | Malaria_Homo sapiens_hsa05144 | 1.14773250 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13555279 |
| 44 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.12623985 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.11648054 |
| 46 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.08189309 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.99302657 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98891996 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98470329 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92256703 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91767156 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91035951 |
| 53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.89308062 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89043118 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.88913797 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 0.86711564 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.86253359 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86057980 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.83980894 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.83725949 |
| 61 | Bile secretion_Homo sapiens_hsa04976 | 0.80002549 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.79455142 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77645631 |
| 64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76997133 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76552066 |
| 66 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74372206 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70749518 |
| 68 | Proteasome_Homo sapiens_hsa03050 | 0.69147514 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66220178 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65609722 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62695307 |
| 72 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62498589 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62214291 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.61363399 |
| 75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.60319346 |
| 76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60121838 |
| 77 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.56585304 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.56119329 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55937159 |
| 80 | Tuberculosis_Homo sapiens_hsa05152 | 0.55470935 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53050713 |
| 82 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52781302 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50741498 |
| 84 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.50265533 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.49813153 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49365892 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48210222 |
| 88 | Measles_Homo sapiens_hsa05162 | 0.48138987 |
| 89 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47891745 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.47353079 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44839083 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43360797 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.40958249 |
| 94 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.39273240 |
| 95 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.39161498 |
| 96 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.38680004 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36321901 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.36036941 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34571010 |
| 100 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.33610568 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32678786 |
| 102 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.32493391 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31896173 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.31455440 |
| 105 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.30938843 |
| 106 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.30847255 |
| 107 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.30201718 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.29813873 |
| 109 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.29426500 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.28923927 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28885958 |
| 112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.28567548 |
| 113 | Hepatitis C_Homo sapiens_hsa05160 | 0.28565906 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28309910 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.28105844 |
| 116 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.27232601 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27056240 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.26467725 |
| 119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26097342 |
| 120 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.25472732 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.25422062 |
| 122 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.25364194 |
| 123 | Tight junction_Homo sapiens_hsa04530 | 0.23676873 |
| 124 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.23533294 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.22765389 |
| 126 | Circadian rhythm_Homo sapiens_hsa04710 | 0.21605902 |
| 127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.20591698 |
| 128 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.18940041 |
| 129 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.11890151 |

